Frontier Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Frontier Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,579	Closed	-$432K	–	372
2020 Q1	$432K	Buy	5,579 +1,023	+22%	+$90.6K	0.07%	185
2019 Q4	$433K	Sell	4,556 -1,012	-18%	-$87.5K	0.07%	197
2019 Q3	$425K	Hold	5,568	–	–	0.06%	209
2019 Q2	$488K	Sell	5,568 -1,138	-17%	-$97.1K	0.07%	194
2019 Q1	$607K	Buy	6,706 +19	+0.3%	+$1.62K	0.08%	197
2018 Q4	$480K	Buy	+6,687	New	+$539K	0.07%	207

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Frontier Wealth Management's XBI Position: Q2 2020 in Review

Frontier Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2020, closing a stake of 5,579 shares — an estimated $432K sold.

Frontier Wealth Management first reported a position in XBI in Q4 2018 and held it in 6 quarters. The position peaked at $607K in Q1 2019. 525 funds tracked by Wall St. Rank hold XBI as of Q2 2020.

Frontier Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2020 after selling out during the quarter.
Frontier Wealth Management sold 5,579 State Street SPDR S&P Biotech ETF shares in Q2 2020, an estimated $432K.
Frontier Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and held it in 6 quarters.
Frontier Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $607K in Q1 2019.
525 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2020.

Based on Frontier Wealth Management's 13F filing for Q2 2020, filed 14 Aug 2020.